In addition to appetite regulation, Semaglutide GLP-1 improves the way the body handles glucose by stimulating insulin release after meals and reducing the release of excess sugar from the liver
The Tesamorelin/Ipamorelin combination provides dual-pathway stimulation of growth hormone releaseGHRH receptor activation and ghrelin receptor activationresulting in: Visceral Fat Reduction & Body Composition Tesamorelin has been shown in clinical trials to significantly reduce visceral adipose tissue while preserving lean body mass, making it one of the most targeted GH-based therapies for central fat reduction
Dierssen-Sotos T, Gmez-Acebo I, de Pedro M, Prez-Gmez B, Servitja S, Moreno V, Amiano P, Fernandez-Villa T, Barricarte A, Tardon A, Diaz-Santos M, Peiro-Perez R, Marcos-Gragera R, Lope V, Gracia-Lavedan E, Alonso MH, Michelena-Echeveste MJ, Garcia-Palomo A, Guevara M, Castao-Vinyals G, Aragons N, Kogevinas M, Polln M, Llorca J (2016) Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: the Spanish multi-case-control (MCC) study
These can improve the early survival rate of patients with prostate cancer